Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin.
Agrawal R, Bahare RS, Jain P, Dikshit SN, Ganguly S.
Mini Rev Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.2174/13895575112091345 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för alogliptin benzoate. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
8 hitsAlogliptin benzoate for the treatment of type 2 diabetes.
Rendell M, Drincic A, Andukuri R.
Expert Opin Pharmacother · research support, non-u.s. gov't; review; journal article · DOI 10.1517/14656566.2012.656088Alogliptin for the treatment of type 2 diabetes.
White JR.
Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2011.47.2.1583163[Pharmacological and clinical profile of alogliptin benzoate (NESINA®)].
Takeuchi K, Fujita T, Hiroi S.
Nihon Yakurigaku Zasshi · review; journal article · DOI 10.1254/fpj.137.43Alogliptin: a review of its use in the management of type 2 diabetes mellitus.
Scott LJ.
Drugs · review; journal article · DOI 10.2165/11205080-000000000-00000A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure.
Asakawa T, Moritoh Y, Kataoka O, Suzuki N, Takeuchi K, Odaka H.
Life Sci · journal article · DOI 10.1016/j.lfs.2009.04.024Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp Clin Pharmacol · bibliography; journal articleChronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H.
Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2008.04.018